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LETTERS TO THE EDITOR
Relationship between plasma
homocysteine concentration
and urinary markers of
tubulointerstitial injury
To the Editor: Francis et al [1] recently reported that
serum homocysteine concentrations are significantly el-
evated in patients with albuminuria and low glomerular
filtration rate (GFR). We previously reported that wean-
ling rats with experimental hyperhomocysteinemia devel-
oped significant tubulointerstitial injury [2], but showed
little glomerular changes, and no significant increases in
proteinuria compared with normal control rats. We con-
cluded that plasma homocysteine correlated with tubu-
lointerstitial injury, rather than with urinary albumin.
Here, we report preliminary data on the relationship
between plasma homocysteine and urinary markers in
healthy subjects. We measured morning urinary albu-
min, a1-microglobulin, and creatinine concentrations,
and plasma homocysteine and creatinine in samples ob-
tained during annual health checkups from 273 healthy
consented subjects (males 174, females 99, mean age
45.7 ± 12.0 years, ±SD). Plasma homocysteine corre-
lated significantly with plasma creatinine (r = 0.347,
P < 0.0001) and urinary a1-microglobulin/creatinine ra-
tio (Fig. 1B), but not with urinary albumin/creatinine ra-
tio (Fig. 1A). Our experimental and clinical data suggest
that elevation of plasma homocysteine might cause sub-
clinical tubulointerstitial damage that is not associated
with albuminuria. In contrast, several studies, including
the study by Francis et al, have shown that renal dys-
function would induce hyperhomocysteinemia [1, 3, 4].
Unfortunately, markers of tubulointerstitial injury were
not measured in these studies. We propose that hyper-
homocysteinemia per se could cause subclinical renal
interstitial injury, and that reduced renal function pro-
motes further rise in plasma homocysteine. Thus, both
hyperhomocysteinemia and renal injury are associated
with each other as pathogenic processes, creating a vi-
cious cycle that results in further deterioration of renal
function.
NAOKI IKEGAYA, CHIE YANAGISAWA, and HIROMICHI KUMAGAI
Shizuoka, Japan
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Fig. 1. Correlation between plasma homocysteine concentration
and urinary albumin/creatinine (A) and urinary a-1 microglobu-
lin/creatinine ratios (B). Plasma homocysteine correlated significantly
with urinary a-1 microglobulin/creatinine ratio (r = 0.219, P =
0.0003), but not with urinary albumin/creatinine ratio (r = 0.014, P =
0.8140).
Correspondence to Naoki Ikegaya, M.D., Ph.D., Professor, Medical
Care Center, Shizuoka University, 836 Ohya, Shizuoka, 422-8529, Japan.
E-mail: ikega-n@adb.shizuoka.ac.jp
REFERENCES
1. FRANCIS ME, EGGERS PW, HOSTETTER TH, BRIGGS JP: Associa-
tion between serum homocysteine and markers of impaired kid-
ney function in adults in the United States. Kidney Int 66:303–312,
2004
2. KUMAGAI H, KATOH S, HIROSAWA K, et al: Renal tubulointersti-
tial injury in weanling rats with hyperhomocysteinemia. Kidney Int
62:1219–1228, 2002
3. WILCKEN DEL, GUPTA VJ: Sulphur-containing amino acids in
chronic renal failure with particular reference to homocysteine and
cysteine-homocysteine mixed disulphide. Eur J Clin Invest 9:301–307,
1979
4. GUTTORMSEN AB, UELAND PM, SVARSTAD E, REFSUM H: Kinetic ba-
sis of hyperhomocysteinemia in patients with chronic renal failure.
Kidney Int 52:495–502, 1997
375
